Amgen Inc. | Amgen | Maryland | state | 2004 | $88,478 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2007 | $88,277 | | tax credit/rebate |
Astellas US Holding, Inc | Astellas Pharma | Illinois | state | 2006 | $87,250 | | grant |
PFIZER INC | Pfizer | Tennessee | local | 2009 | $86,991 | | property tax abatement |
United Therapeutics Corporation and Subsidiaries | United Therapeutics | Maryland | state | 2016 | $86,740 | | tax credit/rebate |
Emergent Biosolutions Inc. and Subsidiaries | Emergent BioSolutions | Maryland | state | 2018 | $86,355 | | tax credit/rebate |
Endo Pharmaceuticals Valera, Inc. | Endo International | New Jersey | state | 2004 | $86,295 | | grant |
American Pharmaceutical Partners, Inc. | Bristol-Myers Squibb | New York | local | 2004 | $85,934 | | tax credit/rebate; property tax abatement |
Shire ViroPharma, Inc. | Takeda Pharmaceutical | Pennsylvania | state | 2016 | $85,794 | | tax credit/rebate |
Novo Nordisk Pharmaceuticals Industries, Inc. | Novo Holdings A/S | North Carolina | state | 2012 | $85,700 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2004 | $85,688 | | tax credit/rebate |
Shire Human Genetic Therapies, Inc. | Takeda Pharmaceutical | Pennsylvania | state | 2015 | $85,593 | | tax credit/rebate |
Depuy Spine, Inc. | Johnson & Johnson | Massachusetts | state | 2011 | $85,255 | | tax credit/rebate |
Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | state | 2013 | $85,010 | | tax credit/rebate |
Hospira, Inc. | Pfizer | North Carolina | state | 2011 | $85,000 | | tax credit/rebate |
Animas Corporation | Johnson & Johnson | Pennsylvania | state | 2008 | $84,072 | | tax credit/rebate |
Schering Corporation | Merck | Florida | state | 2007 | $84,000 | | tax credit/rebate |
Vitae Pharmaceuticals, Inc. (f/k/a Concurrent Pharmaceuticals, Inc.) | AbbVie | Pennsylvania | state | 2014 | $83,843 | | tax credit/rebate |
AbbVie, Inc. | AbbVie | Illinois | state | 2018 | $83,752 | | tax credit/rebate |
Incyte Corporation | Incyte Corp. | Pennsylvania | state | 2021 | $83,700 | | tax credit/rebate |
GlaxoSmithkline Holdings Americas | GlaxoSmithKline | North Carolina | state | 2011 | $83,656 | | tax credit/rebate |
GlaxoSmithkline Holdings Americas , Inc. | GlaxoSmithKline | North Carolina | state | 2010 | $83,656 | | tax credit/rebate |
GlaxoSmithkline Holdings Americas , Inc. | GlaxoSmithKline | North Carolina | state | 2012 | $83,656 | | tax credit/rebate |
GlaxoSmithkline Holdings Americas , Inc. | GlaxoSmithKline | North Carolina | state | 2013 | $83,656 | | tax credit/rebate |
GlaxoSmithkline Holdings Americas , Inc. | GlaxoSmithKline | North Carolina | state | 2015 | $83,656 | | tax credit/rebate |
Jazz Pharmaceuticals, Inc. | Jazz Pharmaceuticals | Pennsylvania | state | 2017 | $83,373 | | tax credit/rebate |
EMERGENT PRODUCT DEVELOPMENT SEATTLE LLC | Emergent BioSolutions | Washington | state | 2014 | $83,367 | | tax credit/rebate |
GILEAD SCIENCES INC | Gilead Sciences | Washington | state | 2011 | $83,248 | | tax credit/rebate |
EMERGENT PRODUCT DEVELOPMENT SEATTLE LLC | Emergent BioSolutions | Washington | state | 2014 | $83,218 | | tax credit/rebate |
Valeant Pharmaceuticals International | Bausch Health | North Carolina | state | 2016 | $82,963 | | tax credit/rebate |
Idexx Operations Inc | IDEXX Laboratories | Maine | state | 2019 | $82,810 | | tax credit/rebate |
Vitae Pharmaceuticals, Inc. | AbbVie | Pennsylvania | state | 2011 | $81,973 | | tax credit/rebate |
Celgene | Bristol-Myers Squibb | New Jersey | state | 2005 | $81,096 | | Tax credit/rebate |
Idexx Operations Inc | IDEXX Laboratories | Maine | state | 2017 | $80,654 | | tax credit/rebate |
MacroGenics, Inc. | MacroGenics | Maryland | state | 2012 | $80,651 | | tax credit/rebate |
MacroGenics, Inc. | MacroGenics | Maryland | state | 2014 | $80,651 | | tax credit/rebate |
Vitae Pharmaceuticals, Inc. | AbbVie | Pennsylvania | state | 2015 | $80,382 | | tax credit/rebate |
Jazz Pharmaceuticals Inc | Jazz Pharmaceuticals | Pennsylvania | state | 2021 | $80,200 | | tax credit/rebate |
Fort Dodge Animal Health | Zoetis | Iowa | state | 2008 | $80,172 | | training reimbursement |
Pfizer, Inc. & Subsidiaries | Pfizer | Maryland | state | 2016 | $79,533 | | tax credit/rebate |
Foundation Medicine Inc. | Roche | Massachusetts | state | 2011 | $78,777 | | tax credit/rebate |
Chimerix, Inc. | Chimerix | North Carolina | state | 2019 | $78,588 | | tax credit/rebate |
Luitpold Pharmaceuticals | Daiichi Sankyo | New York | local | 2010 | $78,586 | | tax credit/rebate; property tax abatement |
Luitpold Pharmaceuticals | Daiichi Sankyo | New York | local | 2011 | $78,586 | | tax credit/rebate; property tax abatement |
BIOSENSE WEBSTER, INC. | Johnson & Johnson | California | state | 2003 | $78,520 | | training reimbursement |
Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | state | 2011 | $78,340 | | tax credit/rebate |
Sanofi Pasteur, Inc. | Sanofi | Pennsylvania | state | 2010 | $78,092 | | tax credit/rebate |
Novartis Gene Therapies, Inc. (formerly AveXi | Novartis | Colorado | state | 2021 | $77,030 | | training reimbursement |
Synthes North America, Inc. | Johnson & Johnson | Pennsylvania | state | 2009 | $76,539 | | tax credit/rebate |
Teva Biopharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | Maryland | state | 2016 | $76,366 | | tax credit/rebate |
Teva Biopharmaceuticals, Inc. | Teva Pharmaceutical Industries | Maryland | state | 2008 | $76,270 | | tax credit/rebate |
IDEXX OPERATIONS INC | IDEXX Laboratories | Maine | state | 2013 | $75,901 | | property tax abatement |
Bausch & Lomb Incorporated | Bausch Health | New York | local | 2022 | $75,893 | | tax credit/rebate |
Idexx Operations Inc | IDEXX Laboratories | Maine | state | 2018 | $75,364 | | tax credit/rebate |
Lightlab Imaging, Inc | Abbott Laboratories | Massachusetts | state | 2011 | $75,148 | | tax credit/rebate |
Novo Nordisk Biochem | Novo Holdings A/S | North Carolina | state | 1994 | $75,000 | | grant |
Purdue Pharma Manufacturing L. P. | Purdue Pharma | North Carolina | state | 2017 | $75,000 | | grant |
United Therapeutics Corporation & Subs. | United Therapeutics | Maryland | state | 2018 | $74,842 | | tax credit/rebate |
Acorda Therapeutics, Inc. | Acorda Therapeutics | New York | local | 2011 | $74,668 | | tax credit/rebate; property tax abatement |
Pharmacia Corporation | Pfizer | Maryland | state | 2008 | $74,621 | | tax credit/rebate |
Astellas US Holding, Inc. | Astellas Pharma | Maryland | state | 2012 | $74,558 | | tax credit/rebate |
Astellas US Holding, Inc. | Astellas Pharma | Maryland | state | 2014 | $74,558 | | tax credit/rebate |
Novartis Vaccines & Diagnostics | Novartis | North Carolina | state | 2009 | $74,375 | | tax credit/rebate |
Regeneron Phase II (aka LOOP Road project) | Regeneron Pharmaceuticals | New York | local | 2022 | $74,201 | | tax credit/rebate |
Immunex Corporation | Amgen | Pennsylvania | state | 2014 | $74,054 | | tax credit/rebate |
Regeneron Pharmaceuticals II | Regeneron Pharmaceuticals | New York | local | 2020 | $74,036 | | tax credit/rebate |
Novira Therapeutics, Inc. | Johnson & Johnson | Pennsylvania | state | 2015 | $73,815 | | tax credit/rebate |
ABBOTT MEDICAL OPTICS INC. | Abbott Laboratories | California | state | 2013 | $73,582 | | training reimbursement |
Luitpold Pharmaceuticals | Daiichi Sankyo | New York | local | 2005 | $73,090 | | tax credit/rebate; property tax abatement |
Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | state | 2010 | $73,000 | | tax credit/rebate |
United Therapeutics Corporation and Subsidiaries | United Therapeutics | Maryland | state | 2015 | $72,866 | | tax credit/rebate |
GILEAD SCIENCES INC | Gilead Sciences | Washington | state | 2010 | $72,840 | | tax credit/rebate |
Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | state | 2013 | $72,693 | | tax credit/rebate |
Pfizer, Inc. | Pfizer | North Carolina | state | 2021 | $72,208 | | tax credit/rebate |
ICOS CORPORATION | Eli Lilly | Washington | state | 2006 | $72,042 | | tax credit/rebate |
GILEAD SCIENCES INC | Gilead Sciences | Washington | state | 2008 | $71,546 | | tax credit/rebate |
BioProtection Systems Corporation | Lumos Pharma | Iowa | state | 2007 | $71,101 | | training reimbursement |
SANOFI AVENTIS US LLC | Sanofi | Washington | state | 2012 | $70,422 | | tax credit/rebate |
SANOFI AVENTIS US LLC | Sanofi | Washington | state | 2013 | $70,422 | | tax credit/rebate |
SANOFI AVENTIS US LLC | Sanofi | Washington | state | 2014 | $70,422 | | tax credit/rebate |
SANOFI-AVENTIS US LLC | Sanofi | Washington | state | 2015 | $70,422 | | tax credit/rebate |
SANOFI-AVENTIS US LLC | Sanofi | Washington | state | 2016 | $70,422 | | tax credit/rebate |
CSL Behring, LLC. | CSL Limited | Pennsylvania | state | 2011 | $70,263 | | tax credit/rebate |
PFIZER INC | Pfizer | Tennessee | local | 2009 | $69,750 | | property tax abatement |
PAREXEL International Corp. | Parexel International | Pennsylvania | state | 2017 | $69,000 | | tax credit/rebate |
Salix Pharmaceuticals, Inc. | Bausch Health | North Carolina | state | 2010 | $68,808 | | tax credit/rebate |
Hospira, Inc. | Pfizer | Kansas | state | 2006 | $68,770 | | training reimbursement |
Otsuka America, Inc. & Subsidiaries | Otsuka Pharmaceutical | Maryland | state | 2018 | $68,671 | | tax credit/rebate |
OMEROS CORP | Omeros Corp. | Washington | state | 2006 | $68,653 | | tax credit/rebate |
Luitpold Pharmaceuticals | Daiichi Sankyo | New York | local | 2004 | $68,264 | | tax credit/rebate; property tax abatement |
Genentech USA Inc | Roche | California | state | 2021 | $68,185 | | training reimbursement |
Depuy Mitek, Inc. | Johnson & Johnson | Massachusetts | state | 2013 | $68,023 | | tax credit/rebate |
AMRI Rensselaer, Inc. | Curia Inc. | New York | state | 2016 | $67,627 | | enterprise zone |
PFIZER INC | Pfizer | Tennessee | local | 2008 | $67,264 | | property tax abatement |
Merck & Co., Inc. | Merck | North Carolina | state | 1999 | $67,000 | | grant |
Auxilium Pharmaceuticals, Inc. | Endo International | Pennsylvania | state | 2015 | $66,990 | | tax credit/rebate |
GILEAD SCIENCES INC | Gilead Sciences | Washington | state | 2009 | $66,838 | | tax credit/rebate |
Pfizer Holdings Americas Corporation | Pfizer | North Carolina | state | 2016 | $66,776 | | tax credit/rebate |
Codman and Shurtleff, Inc. | Johnson & Johnson | Massachusetts | state | 2011 | $66,093 | | tax credit/rebate |
Liquent, Inc. | Parexel International | Pennsylvania | state | 2017 | $65,812 | | tax credit/rebate |
Novo Nordisk, Inc. | Novo Holdings A/S | North Carolina | state | 2016 | $65,650 | | tax credit/rebate |